Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,237

Document Document Title
WO/2021/068815A1
Disclosed in the present invention are a carboxylic acid ester compound and an application thereof, the structure of the compound being shown in general formula I, and the definition of each substituent in general formula I being provide...  
WO/2021/064189A2
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them hig...  
WO/2021/064142A1
The present invention relates to a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof : formula (I) and to pharmac...  
WO/2021/063346A1
A novel KRAS G12C inhibitor. A compound represented by formula (I) and an isomer or pharmaceutically acceptable salt thereof have the following structure. The compound represented by formula (I) and a composition thereof may effectively ...  
WO/2021/066319A2
Provided is a tertiary amine derivative which effectively absorbs a high-energy external light source in the UV region to minimize damage to organic materials in an organic electroluminescent element, thereby contributing to a substantia...  
WO/2021/060723A1
The present invention provides: a compound represented by chemical formula 1; an organic electronic element comprising a first electrode, a second electrode, and an organic layer placed between the first and second electrodes; and an ele...  
WO/2021/019373A4
The present disclosure relates to nitenin analogue compounds (of formulas I, II, III and IV) and their use as pharmaceutical agent in the treatment, prevention or reduction of both acute and chronic pain. The mode of action disclosed her...  
WO/2021/048229A1
The present invention relates to copolymers comprising moieties able to undergo a crosslinking reaction under certain stimuli, thereby forming polymer adducts having improved or additional properties, such as resistance to solvents, incr...  
WO/2021/046447A1
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed com...  
WO/2021/043755A1
The invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.  
WO/2021/037077A1
Patentiflorin A analogs that are useful as antivirals, such as anti-HIV, anti-coronaviral, anti-Ebola viral, and anti-influenza viral agents and methods of use thereof.  
WO/2021/032687A1
A series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives, and analogues thereof, substituted in the 6-position by an arylcarbonylaminophenyl or heteroarylcarbonylaminophenyl moiety, being potent inhibitors of the growth and propa...  
WO/2021/033731A1
Provided is a compound which is represented by formula (1). In the formula, R1-R14, L1-L3, p, q, r, n, and X1 are as defined in the specification.  
WO/2021/034089A1
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device including the organic electronic element. According to the present invention, an organic el...  
WO/2020/254552A3
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glu...  
WO/2021/028362A1
The present invention relates to new compounds capable of inhibiting the activity of SHP2 phosphatase, having the general Formula (I).  
WO/2021/023572A1
The present invention relates to amides of formula (I), wherein the variables are defined according to the description, process for preparation, their use as herbicides, i.e. for controlling harmful plants, and also a method for controll...  
WO/2021/019373A1
The present disclosure relates to nitenin analogue compounds (of formulas I, II, III and IV) and their use as pharmaceutical agent in the treatment, prevention or reduction of both acute and chronic pain. The mode of action disclosed her...  
WO/2021/013799A1
The invention relates to substituted N-phenyl uracils of the general formula (I) or salts (I) thereof, wherein the groups in the general formula (I) are as defined in the description, and to the use thereof as herbicides, more specifical...  
WO/2021/008491A1
Biphenyl derivatives having a structure of formula (I) and capable of blocking PD-1/PD-L1 interaction, a preparation method therefor and use thereof. The series of compounds can be widely used in the preparation of medicaments for preven...  
WO/2021/007659A1
This disclosure relates to cannabinoid derivatives having the structure of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives in the treatment or prevention of a disease associated ...  
WO/2021/004388A1
Crystal form A of a compound represented by formula (I) and an application thereof in preparing a drug for treating an SGLT1/SGLT2-related disease.  
WO/2020/259471A1
Provided herein are oseltamivir analogs useful for the treatment and prevention of viral infections, pharmaceutical compositions comprising the same and methods preparation and use thereof.  
WO/2020/260857A1
The present invention relates to compounds of formula I shown below: (I) wherein R1, R2 and R3 are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceuti...  
WO/2020/254552A2
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glu...  
WO/2020/255021A1
Therapeutic combinations of hepatitis B virus (HBV) vaccines and a small molecule PDL1 or PD1 inhibitor are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals hav...  
WO/2020/244518A1
The present invention provides a compound with benzyloxy aromatic ring structure represented by general formula (I), a stereoisomer, enantiomer or pharmaceutically acceptable salt thereof, a preparation method thereof, a pharmaceutical c...  
WO/2020/245665A1
Compounds of formula (I) wherein ring B is selected from the group consisting of Formula (B-a) and Formula (B-bc) as human cytidine triphosphate synthase 1 ( CTPS1) inhibitors for the treatment of proliferative diseases, such as e.g. can...  
WO/2020/239856A1
Compounds of the formula (I), wherein the substituents are as defined in claim 1, useful as pesticides, and especially fungicides.  
WO/2020/243754A1
Provided herein is a method of forming a beta-lactone from a carboxylic acid having a beta-carbon with a hydrogen atom disposed thereon. The method comprises contacting a carboxylic acid of formula (1) as described herein with an effecti...  
WO/2020/233694A1
Disclosed are a crystal form (I) of a pyrimidine sulfonamide compound and a preparation method therefor. The present invention relates to an application thereof in the preparation of a medicament for treating diseases related to ETA rece...  
WO/2020/228513A1
The present invention relates to the field of biomedicine, and specifically comprises a series of derivatives of a novel CDK9 inhibitor having a benzopyran structure and use thereof. In view of the disadvantages of low anti-tumor activit...  
WO/2020/228789A1
The present invention relates to a 3-aryloxyl-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof. Specifically, the present invention provides a compound, or a pharmaceutically acceptable salt or a prodrug ...  
WO/2020/223538A1
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.  
WO/2020/216701A1
The present invention provides acyl sulfonamide compounds of general formula (I): in which X, R1, R2, R3, R4, R5, R6, Ra and Rb are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for p...  
WO/2020/218680A1
The present invention relates to a novel organic light emitting compound and an organic electroluminescent diode using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light emitt...  
WO/2020/216034A1
Provided are an intermediate which can be used for synthesizing halichondrin B, eribulin or an analogue thereof, in particular a C27-C35 structure fragment thereof, a preparation method therefor and use thereof. The starting raw material...  
WO/2020/218187A1
An organic electroluminescent element which comprises a light emitting layer between a positive electrode and a negative electrode facing each other, and which is characterized in that: the light emitting layer contains a first host, a s...  
WO/2020/210308A1
The present disclosure relates to compounds of Formula (I) or (II), which inhibit Gal-3, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions.  
WO/2020/209035A1
A compound represented by formula (1). R1 is, for example, an alkyl having 1-15 carbon atoms; ring A1 and ring A2 are 1,4-phenylene, etc.; a is 2, etc.; b and c are 0, 1, or 2; Z1 is a single bond, etc.; P1 and P2 are polymerizable group...  
WO/2020/205683A1
In immunoglobulin light chain amyloidosis (AL), the unique antibody light chain (LC) protein that is secreted by monoclonal plasma cells in each patient misfolds and/or aggregates, a process leading to organ degeneration. For treating AL...  
WO/2020/189391A1
The present invention pertains to: a scytalone dehydratase inhibitor which contains at least one compound selected from the compounds represented by formula (I) (in the formula, A1-A4 each represents CH or N; R is a substituent other tha...  
WO/2020/191091A1
This invention provides for compounds of the formula wherein the variables are defined herein, or a stereoisomer, tautomer, N-oxide, hydrate, solvate, or salt thereof, compositions comprising these compounds, and method for the treatment...  
WO/2020/188437A1
The present invention relates to compounds with a 5-(2-nitroethyI)-2,4,6- triaminopyrimidine structure, derivatised at the 1 position on the ethylene chain with heteroaromatic or phenyl-benzylether rings. The invention also relates to th...  
WO/2020/188183A1
The invention relates to a process for producing a polybenzoxazine monomer, the crosslinking thereof, and the use of the crosslinked product to form ablative thermal protection for a propelling nozzle or a body for atmospheric re-entry.  
WO/2020/188182A1
The invention relates to a process for producing a polybenzoxazine monomer, the crosslinking thereof and the use of the crosslinked product to form an ablative thermal protection for a thruster nozzle or an atmospheric re-entry body.  
WO/2020/185420A1
Provided herein are integrated methods and systems for the production of acrylamide and acrylonitrile compounds and other compounds from at least beta-lactones and/or beta-hydroxy amides.  
WO/2020/178404A1
The present invention relates to herbicidally active pyridazine derivatives of Formula (I) as defined herein, as well as to herbicidal compositions comprising such derivatives, and the use of such compounds and compositions for controlli...  
WO/2020/176505A1
The present disclosure relates generally to certain diacylglycerol lactone compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds an...  
WO/2020/175688A1
[Problem] To provide a fluorescent probe capable of detecting breast cancer, lung cancer, and squamous cell cancer. [Solution] A fluorescent probe for detecting breast cancer and benign tumors of the breast, the probe containing a compou...  

Matches 1 - 50 out of 7,237